Astelllas Names Global PV Head

Songlin Xue, M.D., Ph.D., has been named head of Global Pharmacovigilance at Astellas Pharma, Inc. Dr. Xue will be based at Astellas’ headquarters for the Americas in Northbrook, IL, and will report to Sef Kurstjens, M.D., Ph.D., chief medical officer at Astellas.
 
Dr. Xue has more than 20 years of pharmaceutical industry experience, and has held increasingly senior roles with global responsibilities in drug safety and pharmacoepidemiology. Most recently, Dr. Xue served as senior vice president, head Global Pharmacovigilance at Takeda Pharmaceuticals, Inc. Prior to joining Takeda, Dr. Xue held positions with Novartis and Wyeth.

Astellas president and chief executive officer Yoshihiko Hatanaka said, “I am pleased that Dr. Xue will be joining us at Astellas as head of Global Pharmacovigilance. Dr. Xue’s knowledge and experience will help the company pursue its operational excellence and further enhance our global PV and product compliance capabilities.”